MK-4002 clinical trials

Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)

This study is looking into a new treatment called MK-4002 (or HPN217) for people with multiple myeloma that has come back or is no longer responding to usual treatments. Researchers want to find a safe dose and understand how the body handles the medicine.